"nor is there any high quality evidence supporting the mental health claims made for the gender-affirming model." I don't think there is any moderate quality evidence either? In the US an incorrect impression is often given that the choices are either high or low quality. As high quality has stringent requirements, this can be used to imply low quality is enough, even for treatments that are likely to sterilize minors and young people. Block, on her BMJ article on gender dysphoria quotes expert Dr. Guyatt on how low quality should not be used to make strong recommendations except in very specific circumstances.
Extensive scientific studies of large populations of individuals on the autism spectrum indicate a very high rate of suicidal ideation and completed suicide. The same cohort (individuals on the autism spectrum) are up to six times more likely to identify as transgender.
The Royal Children’s Hospital estimates that approximately 1.2% of Australian school children (45,000) identify as transgender.
The suicide rate for Australian indigenous children is approximately 8.3 deaths per 100,000 population, equating to just under 4 per 45,000.
I am unable to find any reference to a single Australian child with gender dysphoria having suicided (and hope that this is the case).
However, if these figures are even somewhere near reality then it would suggest that the problem in relation to child suicides is not with the gender dysphoria cohort but with our indigenous children and perhaps the resources to address it should be focussed there.
"In a statement on 4 June reported by Norway’s NTB news agency, the directorate suggested that puberty blockers or hormones might be made available to minors only through the specialised health service.2 Guldvog told the news agency that national changes could lead to “stricter requirements” for giving hormone treatment to children, suggesting that Norway would follow national guidance in Finland, Sweden, and the UK to limit such treatment in minors to clinical research."
Thank you!
"nor is there any high quality evidence supporting the mental health claims made for the gender-affirming model." I don't think there is any moderate quality evidence either? In the US an incorrect impression is often given that the choices are either high or low quality. As high quality has stringent requirements, this can be used to imply low quality is enough, even for treatments that are likely to sterilize minors and young people. Block, on her BMJ article on gender dysphoria quotes expert Dr. Guyatt on how low quality should not be used to make strong recommendations except in very specific circumstances.
Extensive scientific studies of large populations of individuals on the autism spectrum indicate a very high rate of suicidal ideation and completed suicide. The same cohort (individuals on the autism spectrum) are up to six times more likely to identify as transgender.
Perhaps hormones and surgery are not the answer?
The Royal Children’s Hospital estimates that approximately 1.2% of Australian school children (45,000) identify as transgender.
The suicide rate for Australian indigenous children is approximately 8.3 deaths per 100,000 population, equating to just under 4 per 45,000.
I am unable to find any reference to a single Australian child with gender dysphoria having suicided (and hope that this is the case).
However, if these figures are even somewhere near reality then it would suggest that the problem in relation to child suicides is not with the gender dysphoria cohort but with our indigenous children and perhaps the resources to address it should be focussed there.
I just saw this:
"In a statement on 4 June reported by Norway’s NTB news agency, the directorate suggested that puberty blockers or hormones might be made available to minors only through the specialised health service.2 Guldvog told the news agency that national changes could lead to “stricter requirements” for giving hormone treatment to children, suggesting that Norway would follow national guidance in Finland, Sweden, and the UK to limit such treatment in minors to clinical research."
https://www.bmj.com/content/382/bmj.p1572